By Hailey Konnath ( August 15, 2022, 11:22 PM EDT) -- The First Circuit on Friday partially revived portions of Azurity Pharmaceuticals' suit against Edge Pharma over its competing hydrochloride vancomycin drug, agreeing with a Massachusetts federal court that some of its claims don't hold up, but not for the same reason. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.